These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 6994208)

  • 1. Eradication of poliomyelitis in the United States. III. Poliovaccines--practical considerations.
    Salk D
    Rev Infect Dis; 1980; 2(2):258-73. PubMed ID: 6994208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eradication of poliomyelitis in the United States. II. Experience with killed poliovirus vaccine.
    Salk D
    Rev Infect Dis; 1980; 2(2):243-57. PubMed ID: 6771867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eradication of poliomyelitis in the United States. I. Live virus vaccine-associated and wild poliovirus disease.
    Salk D
    Rev Infect Dis; 1980; 2(2):228-42. PubMed ID: 6994207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccinology of poliomyelitis.
    Salk D; Salk J
    Vaccine; 1984 Mar; 2(1):59-74. PubMed ID: 6099644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decision analysis in planning for a polio outbreak in the United States.
    Jenkins PC; Modlin JF
    Pediatrics; 2006 Aug; 118(2):611-8. PubMed ID: 16882814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eradication of poliomyelitis in the United States.
    Nathanson N
    Rev Infect Dis; 1982; 4(5):940-50. PubMed ID: 7146731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Introduction to Poliovirus: Pathogenesis, Vaccination, and the Endgame for Global Eradication.
    Minor PD
    Methods Mol Biol; 2016; 1387():1-10. PubMed ID: 26983727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poliomyelitis prevention in the United States: introduction of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    MMWR Recomm Rep; 1997 Jan; 46(RR-3):1-25. PubMed ID: 9026708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poliomyelitis prevention: enhanced-potency inactivated poliomyelitis vaccine--supplementary statement.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1987 Dec; 36(48):795-8. PubMed ID: 3119980
    [No Abstract]   [Full Text] [Related]  

  • 10. Antibody response and viral excretion after live polio vaccine or a combined schedule of live and inactivated polio vaccines.
    Ramsay ME; Begg NT; Gandhi J; Brown D
    Pediatr Infect Dis J; 1994 Dec; 13(12):1117-21. PubMed ID: 7892081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Inactivated poliovirus vaccines: an inevitable choice for eliminating poliomyelitis].
    Vidor JD; Jean-Denis S
    Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Dec; 50(12):1021-1031. PubMed ID: 28057103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leads from the MMWR. Poliomyelitis prevention: enhanced-potency inactivated poliomyelitis vaccine--supplementary statement.
    JAMA; 1988 Jan; 259(3):345-6. PubMed ID: 3336150
    [No Abstract]   [Full Text] [Related]  

  • 13. Rationale for the sequential use of inactivated poliovirus vaccine and live attenuated poliovirus vaccine for routine poliomyelitis immunization in the United States.
    McBean AM; Modlin JF
    Pediatr Infect Dis J; 1987 Oct; 6(10):881-7. PubMed ID: 3320922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poliovirus vaccination: a trilogy.
    Faden H
    J Infect Dis; 1993 Jul; 168(1):25-8. PubMed ID: 8515124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perspectives on rapid elimination and ultimate global eradication of paralytic poliomyelitis caused by polioviruses.
    Sabin AB
    Eur J Epidemiol; 1991 Mar; 7(2):95-120. PubMed ID: 1646116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunization against poliomyelitis: risk/benefit/cost in a changing context.
    Salk J
    Dev Biol Stand; 1979; 43():151-7. PubMed ID: 230106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anomalous observations on IPV and OPV vaccination.
    John TJ
    Dev Biol (Basel); 2001; 105():197-208. PubMed ID: 11763328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effectiveness of different strategies of vaccine prophylaxis for poliomyelitis in the Ukraine].
    Moĭseieva HV; Zadorozhna VI
    Lik Sprava; 2002; (2):85-8. PubMed ID: 12073271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recommendations for a national policy on poliomyelitis vaccination.
    Nightingale EO
    N Engl J Med; 1977 Aug; 297(5):249-53. PubMed ID: 195207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inactivated poliovirus vaccine given alone or in a sequential schedule with bivalent oral poliovirus vaccine in Chilean infants: a randomised, controlled, open-label, phase 4, non-inferiority study.
    O'Ryan M; Bandyopadhyay AS; Villena R; Espinoza M; Novoa J; Weldon WC; Oberste MS; Self S; Borate BR; Asturias EJ; Clemens R; Orenstein W; Jimeno J; Rüttimann R; Costa Clemens SA;
    Lancet Infect Dis; 2015 Nov; 15(11):1273-82. PubMed ID: 26318714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.